Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
33.50
+1.00 (3.08%)
Apr 29, 2026, 5:24 PM IDT

TLV:CBI Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
5148556298185
Upgrade
Market Cap Growth
-6.61%-12.89%-12.09%-36.78%-46.87%-41.79%
Upgrade
Enterprise Value
707491109144336
Upgrade
Last Close Price
0.330.300.350.400.631.18
Upgrade
PS Ratio
---598.73266.21827.64
Upgrade
PB Ratio
2.232.081.190.510.680.55
Upgrade
P/TBV Ratio
2.522.361.490.630.78-
Upgrade
EV/Sales Ratio
---1046.55389.641498.60
Upgrade
EV/EBITDA Ratio
----28.0634.03
Upgrade
Debt / Equity Ratio
0.780.780.450.300.250.16
Upgrade
Debt / EBITDA Ratio
----7.155.45
Upgrade
Net Debt / Equity Ratio
0.700.700.340.190.170.00
Upgrade
Net Debt / EBITDA Ratio
-3.56-3.56-2.49-2.324.640.07
Upgrade
Net Debt / FCF Ratio
-4.07-4.07-2.44-2.63-0.39-0.02
Upgrade
Asset Turnover
---0.000.000
Upgrade
Quick Ratio
0.100.100.252.014.651.70
Upgrade
Current Ratio
0.140.140.292.215.712.18
Upgrade
Return on Equity (ROE)
-58.43%-58.43%-89.60%-21.10%-16.98%-15.63%
Upgrade
Return on Assets (ROA)
-5.39%-5.39%-3.67%-3.73%-2.49%-1.49%
Upgrade
Return on Capital Employed (ROCE)
-19.50%-19.50%-13.90%-6.70%-7.00%-3.10%
Upgrade
Earnings Yield
-26.13%-27.93%-114.10%-49.87%-62.68%-48.32%
Upgrade
FCF Yield
--8.28%-11.83%-13.68%-61.23%-23.15%
Upgrade
Buyback Yield / Dilution
----1.01%1.74%
Upgrade
Total Shareholder Return
----1.01%1.74%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.